Who are we?


Signup for

Online registration

Log in to register
your trial

Search a trial




van CCT (UK)

van CCT (UK)

Evaluatie van een nieuwe optische beeldvormingstechniek voor de detectie van de schildwachtklier bij patienten met borstkanker.

- candidate number5429
- NTR NumberNTR1700
- ISRCTNISRCTN wordt niet meer aangevraagd
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR9-mrt-2009
- Secondary IDsBICG26UMCG-NIRF ICG enhanced SLNB
- Public TitleEvaluatie van een nieuwe optische beeldvormingstechniek voor de detectie van de schildwachtklier bij patienten met borstkanker.
- Scientific TitleEvaluation of Indocyanine Green (ICG) enhanced Near-InfraRed Fluorescence (NIRF) Imaging for Intra-Operative Sentinel Lymph Node (SLN) detection in Breast-conserving Surgery.
- hypothesisThis non-inferiority study specifies as a null hypothesis that ICG enhanced NIRF imaging is inferior in detecting sentinel lymph nodes compared to the current standard treatment (technetium-99m combined with Patent Blue).
- Healt Condition(s) or Problem(s) studiedBreast cancer
- Inclusion criteriaPatient with operable stage I-II breast cancer diagnosed preoperatively by core biopsy or cytology (cT1-2N0).
- Exclusion criteria1. Refusal of the patient to be included in the study;
2. Pregnant or breast-feeding;
3. Significant renal dysfunction (serum creatinine above 400 micromol/L);
4. cardiac and/or pulmonary disease (ASA III-IV);
5. History of iodine allergy or anaphylactic reactions to insect bites or medication;
6. Presence or history of hyperthyroidism;
7. Recent surgery on the armpit.
- mec approval receivedno
- multicenter trialyes
- randomisedno
- group[default]
- TypeSingle arm
- Studytypeintervention
- planned startdate 1-mei-2009
- planned closingdate1-mei-2011
- Target number of participants200
- InterventionsPatients with operable breast cancer stage I-II undergoing a lumpectomy, combined with a sentinel lymph node procedure, will receive prior to a lumpectomy and SLN procedure an intratumoral injection with indocyanin green (ICG). During the operative procedure NIRF imaging for detection of the SLN (i.e. ICG accumulation) will take place.
- Primary outcomeWhether ICG enhanced NIRF imaging is able to detect sentinel lymph nodes as good as or better than the standard technique (technetium-99 labelled colloid and Patent Blue) during breast surgery in 97% 2% of the cases.
- Secondary outcomeThe number of lymph nodes detected by ICG enhanced NIRF imaging during breast surgery.
- TimepointsDay of surgery.
- Trial web siteN/A
- statusplanned
- Sponsor/Initiator University Medical Center Groningen (UMCG), Department of Surgery
- Funding
(Source(s) of Monetary or Material Support)
University Medical Center Utrecht (UMCU), Department of Surgery
- Publications1. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Tagaya N, Yamazaki R, Nakagawa A, Abe A, Kiyoshige H, Kubota K, Oyama T. Am J Surg 2008;195:850-853.
2. Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer. Ogasawara Y, Ikeda H, Takahashi M, Karasaki K, Doihara H. World J Surg 2008;32:1924-1929.
3. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluophore: Feasibility study. Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blachard DK, Fischer RE, Chiang SB, Elledge R, Mawad ME. Radiology 2008; 246: 734-741.
- Brief summaryRationale:
This project consists on the clinical validation of an imaging modality dedicated to sentinel lymph nodes identification and localization in the case of breast cancer. An intra-operative near-infrared fluorescence imaging camera will be evaluated for its ability to detect the sentinel lymph node (SLN) in patients with breast cancer compared to the standard procedure in a non-inferiority study design. The sentinel lymph node technique, based on the propagation of cancer cells in the lymphatic system, allows a better evaluation of tumor staging, prognosis and therapeutic strategy determination. The end-goal is to significantly improve the detection and efficiency of the technique in order to reduce the false negative rate and then the recurrence risk, as well as the operative morbidity in future studies on near-infrared tumor-targeted optical contrast agents.
- Main changes (audit trail)
- RECORD9-mrt-2009 - 14-sep-2009

  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar